EG622976 Inhibitors
Gm6377, a predicted gene associated with the regulation of lysosomal lumen pH, plays a pivotal role in maintaining cellular homeostasis by modulating the acidity of lysosomal compartments. Lysosomes, integral components of cellular degradation and recycling processes, rely on precise pH regulation for optimal functionality. The predicted involvement of Gm6377 in controlling lysosomal lumen pH underscores its significance in orchestrating the delicate balance required for proper cellular functioning. This gene's potential impact on lysosomal pH regulation suggests its involvement in critical cellular processes, as lysosomes are central to the degradation of cellular waste, recycling of biomolecules, and overall cellular health.
Inhibition of Gm6377, whether achieved directly or indirectly through various chemical compounds, sheds light on the intricate mechanisms influencing lysosomal pH regulation. Chemical inhibitors identified in the table, such as Bafilomycin A1 and Concanamycin A, directly target vacuolar-type H+-ATPase (V-ATPase), a key player in lysosomal acidification. These inhibitors disrupt the pump's proton-translocating activity, leading to an increase in lysosomal pH and impacting Gm6377's function. Additionally, other inhibitors indirectly influence Gm6377 by altering cellular processes related to lysosomal function. For instance, Wortmannin, a phosphoinositide 3-kinase (PI3K) inhibitor, affects vesicular trafficking, potentially influencing the lysosomal environment regulated by Gm6377. The varied mechanisms of inhibition highlight the complexity of Gm6377's role in lysosomal pH regulation, emphasizing its integration into cellular processes essential for maintaining cellular health and functionality. Understanding the nuanced interplay between Gm6377 and its inhibitors provides valuable insights into the broader landscape of lysosomal biology and the intricate web of cellular processes regulated by this predicted gene.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
Bafilomycin A1 inhibits vacuolar-type H+-ATPase (V-ATPase), disrupting lysosomal acidification by targeting the proton pump, leading to an increase in lysosomal lumen pH. This directly impacts Gm6377, predicted to regulate lysosomal lumen pH. | ||||||
Concanamycin A | 80890-47-7 | sc-202111 sc-202111A sc-202111B sc-202111C | 50 µg 200 µg 1 mg 5 mg | $66.00 $167.00 $673.00 $2601.00 | 109 | |
Concanamycin A, like Bafilomycin A1, inhibits V-ATPase, impeding lysosomal acidification. This indirectly hinders the function of Gm6377, which is implicated in the regulation of lysosomal lumen pH. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine raises lysosomal pH by accumulating in lysosomes, preventing their acidification. This indirectly affects Gm6377, contributing to its predicted role in lysosomal lumen pH regulation. | ||||||
Lys05 | 1391426-24-6 | sc-507532 | 5 mg | $140.00 | ||
Lys05 is a lysosomotropic agent that disrupts lysosomal function, impacting Gm6377 indirectly by altering the lysosomal environment crucial for its predicted involvement in the regulation of lysosomal lumen pH. | ||||||
E-64 | 66701-25-5 | sc-201276 sc-201276A sc-201276B | 5 mg 25 mg 250 mg | $281.00 $947.00 $1574.00 | 14 | |
E-64d is a cysteine protease inhibitor that can indirectly affect Gm6377 by altering the proteolytic environment within lysosomes, potentially influencing the regulatory mechanisms involved in lysosomal lumen pH. | ||||||
FCM Lysing solution (1x) | sc-3621 | 150 ml | $62.00 | 8 | ||
This solution raises lysosomal pH by inhibiting lysosomal acidification, impacting Gm6377 indirectly by modulating the lysosomal environment essential for its predicted role in lysosomal lumen pH regulation. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin inhibits phosphoinositide 3-kinases (PI3K), affecting vesicular trafficking. This could indirectly influence Gm6377 by altering the lysosomal environment and its involvement in the regulation of lysosomal lumen pH. | ||||||
Leupeptin hemisulfate | 103476-89-7 | sc-295358 sc-295358A sc-295358D sc-295358E sc-295358B sc-295358C | 5 mg 25 mg 50 mg 100 mg 500 mg 10 mg | $73.00 $148.00 $316.00 $499.00 $1427.00 $101.00 | 19 | |
Leupeptin, a protease inhibitor, can indirectly impact Gm6377 by altering lysosomal proteolytic activity, potentially influencing its role in the regulation of lysosomal lumen pH. | ||||||
Glyburide (Glibenclamide) | 10238-21-8 | sc-200982 sc-200982A sc-200982D sc-200982B sc-200982C | 1 g 5 g 25 g 100 g 500 g | $46.00 $61.00 $117.00 $173.00 $530.00 | 36 | |
Glyburide, an ATP-sensitive potassium channel inhibitor, may indirectly influence Gm6377 by modulating cellular ion homeostasis, impacting the lysosomal environment crucial for Gm6377's predicted role in the regulation of lysosomal lumen pH. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
Dynasore inhibits dynamin, affecting endocytic vesicle formation. This could indirectly impact Gm6377 by altering vesicular trafficking, influencing the lysosomal environment crucial for Gm6377's predicted role in the regulation of lysosomal lumen pH. | ||||||